you are here:

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals

BSE Live

Jun 16, 16:00
1131.25 24.90 (2.25%)
Volume
AVERAGE VOLUME
5-Day
96,161
10-Day
70,727
30-Day
64,594
70,886
  • Prev. Close

    1106.35

  • Open Price

    1120.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jun 16, 15:59
1130.75 23.45 (2.12%)
Volume
AVERAGE VOLUME
5-Day
941,524
10-Day
780,327
30-Day
1,021,667
1,423,886
  • Prev. Close

    1107.30

  • Open Price

    1110.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1130.75 (1383)

Financials

2020 2019 2018 2017 2016
Cash Flow of Natco Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 583.10 847.40 887.60 634.10 221.50  
Net CashFlow From Operating Activities 422.50 698.80 476.40 329.80 189.90  
Net Cash Used In Investing Activities -165.00 -645.20 -1,131.10 -290.60 -249.30  
Net Cash Used From Financing Activities -261.10 -52.20 652.00 -45.60 151.40  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 1.20  
Net Inc/Dec In Cash And Cash Equivalents -3.60 1.40 -2.70 -6.40 93.20  
Cash And Cash Equivalents Begin of Year 11.50 10.10 12.80 19.20 -170.00  
Cash And Cash Equivalents End Of Year 7.90 11.50 10.10 12.80 -76.80  
Source : Dion Global Solutions Limited